 |
 |

Sézary SyndromeA Malignant Leukemic Reticuloendotheliosis
LT LUKE G. TEDESCHI, MC;
LT CDR DONALD T. LANSINGER, MC
Arch Dermatol. 1965;92(3):257-262.
Abstract
Review of the literature and the study of a case associated with a malignant lymphoma strongly suggests that the Sézary syndrome is merely a clinical variant of mycosis fungoides. Additional evidence is presented that the lymphadenopathy of the Sézary syndrome is not always of a benign nature, as originally indicated in the literature. Both the Sézary syndrome and mycosis fungoides share the unpredictability of the neoplastic processes of the reticular system which are likely to involve simultaneously or successively, the skin and the lymph-hematopoietic system, as well as the ability of the cell involved in the process to invade the blood stream, giving rise to the leukemic variety of the malignant reticulosis.
Author Affiliations
USNR; USNR, CAMP PENDLETON, CALIF
From the Departments of Pathology and Dermatology, United States Naval Hospital, Camp Pendleton, Calif. Lt Tedeschi is now at Framingham Union Hospital, Framingham, Mass.
Footnotes
Accepted for publication May 14, 1965.
The views expressed in this paper are those of the authors, and do not represent official Naval policy.
Reprint requests to Department of Pathology, Framingham Union Hospital, Framingham, Mass 01701 (Dr. Tedeschi).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cutaneous T-Cell Lymphomas: The Sezary Syndrome, Mycosis Fungoides, and Related Disorders
LUTZNER et al.
ANN INTERN MED 1975;83:534-552.
ABSTRACT
|